HK1041284B - 造血細胞移植 - Google Patents

造血細胞移植

Info

Publication number
HK1041284B
HK1041284B HK02101109.4A HK02101109A HK1041284B HK 1041284 B HK1041284 B HK 1041284B HK 02101109 A HK02101109 A HK 02101109A HK 1041284 B HK1041284 B HK 1041284B
Authority
HK
Hong Kong
Prior art keywords
transplantation
disease
haematopoietic cells
treatment
stem cells
Prior art date
Application number
HK02101109.4A
Other languages
English (en)
Other versions
HK1041284A1 (en
Inventor
Price Jack
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Publication of HK1041284A1 publication Critical patent/HK1041284A1/xx
Publication of HK1041284B publication Critical patent/HK1041284B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
HK02101109.4A 1999-02-24 2002-02-15 造血細胞移植 HK1041284B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (2)

Publication Number Publication Date
HK1041284A1 HK1041284A1 (en) 2002-07-05
HK1041284B true HK1041284B (zh) 2003-10-03

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02101109.4A HK1041284B (zh) 1999-02-24 2002-02-15 造血細胞移植

Country Status (20)

Country Link
EP (1) EP1161521B1 (zh)
JP (1) JP4716575B2 (zh)
KR (1) KR20020000216A (zh)
CN (1) CN1636053A (zh)
AT (1) ATE237680T1 (zh)
AU (1) AU762763B2 (zh)
CA (1) CA2361401A1 (zh)
CZ (1) CZ20012651A3 (zh)
DE (1) DE60002185T2 (zh)
DK (1) DK1161521T3 (zh)
ES (1) ES2193938T3 (zh)
GB (1) GB9904281D0 (zh)
HK (1) HK1041284B (zh)
HU (1) HUP0105168A3 (zh)
NO (1) NO20014091D0 (zh)
PL (1) PL350297A1 (zh)
PT (1) PT1161521E (zh)
RU (1) RU2216336C2 (zh)
SK (1) SK11232001A3 (zh)
WO (1) WO2000050568A2 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
JP2002544234A (ja) * 1999-05-14 2002-12-24 ヘンリー フォード ヘルス システム 発作の処置のための骨髄移植
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US7635467B2 (en) * 2002-01-14 2009-12-22 The Board Of Trustees Of The University Of Illinois Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
KR20050086606A (ko) * 2002-11-15 2005-08-30 가부시키가이샤 상가쿠렌케이키코큐슈 장기의 재생 방법
ES2294650T3 (es) 2004-09-30 2008-04-01 Reneuron Limited Linea celular.
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
EP3424507A1 (en) * 2006-03-24 2019-01-09 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
EP3824885A1 (en) 2006-10-20 2021-05-26 Children's Medical Center Corporation Method to enhance tissue regeneration
JP5555922B2 (ja) 2008-09-16 2014-07-23 ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド 脱毛を治療する、又は、脱毛の発症を遅らせるための組成物
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
PL2699247T3 (pl) * 2011-04-20 2018-09-28 The Regents Of The University Of California Sposób połączonego wzbogacania i chemoselekcji w pojedynczym cyklu
CN112410298A (zh) 2011-12-02 2021-02-26 菲特治疗公司 增强的干细胞组合物
JP6106688B2 (ja) 2011-12-02 2017-04-05 フェイト セラピューティクス，インコーポレイテッド 虚血を処置する改善された方法
US10851412B2 (en) 2013-03-15 2020-12-01 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
JPH07504331A (ja) * 1992-03-04 1995-05-18 システミックス，インコーポレイティド 造血幹細胞の培養およびその遺伝子工学
EP0835098B1 (de) * 1995-06-27 2002-09-04 Boehringer Ingelheim Pharma KG Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
BR9711204A (pt) * 1996-08-19 1999-08-17 Univ Massachusetts Linhagens de c-lulas embriÄnicas ou similares s indiferenciadas produzidas por transplante nuclear de esp-cies hibridas

Also Published As

Publication number Publication date
AU762763B2 (en) 2003-07-03
JP2002537406A (ja) 2002-11-05
WO2000050568A3 (en) 2000-12-07
CZ20012651A3 (cs) 2002-01-16
GB9904281D0 (en) 1999-04-21
EP1161521A2 (en) 2001-12-12
DE60002185T2 (de) 2003-12-18
WO2000050568A2 (en) 2000-08-31
KR20020000216A (ko) 2002-01-05
CN1636053A (zh) 2005-07-06
NO20014091L (no) 2001-08-23
DE60002185D1 (de) 2003-05-22
AU2682100A (en) 2000-09-14
PT1161521E (pt) 2003-08-29
ES2193938T3 (es) 2003-11-16
HK1041284A1 (en) 2002-07-05
ATE237680T1 (de) 2003-05-15
NO20014091D0 (no) 2001-08-23
PL350297A1 (en) 2002-12-02
EP1161521B1 (en) 2003-04-16
JP4716575B2 (ja) 2011-07-06
SK11232001A3 (sk) 2002-01-07
RU2216336C2 (ru) 2003-11-20
CA2361401A1 (en) 2000-08-31
HUP0105168A3 (en) 2003-12-29
DK1161521T3 (da) 2003-06-16
HUP0105168A2 (hu) 2002-05-29

Similar Documents

Publication Publication Date Title
PL350297A1 (en) Transplantation of haematopoietic cells
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
GB2367060B (en) Alzheimer's disease secretase,app substrates therefor,and uses therefor
MXPA02004881A (es) Genes de rasgos o cualidades de las semillas.
SG129236A1 (en) Somatic pluripotent cells
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
SI1303272T1 (sl) Derivati benzotiazola za zdravljenje alzheimerjeve bolezni in parkinsonove bolezni
AU2003220096A1 (en) Methods for alzheimer's disease treatment and cognitive enhancement
MXPA02003733A (es) Metodos para producir celulas progenitoras diferenciadas y celulas troncales embrionicas de lineas de descendencia defectivas.
AU2002319615A1 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
AU5716898A (en) Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
CA2336833A1 (en) Remedy with antidepressant effects
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
HK1075673A1 (en) Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
AU1441397A (en) Moulded spherical ceramic body, a manufacturing process for this, and the use thereof
HK1080408B (zh) 溴莫尼定在治療痴呆和帕金森病中的用途
EP1152762B8 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
GB9914616D0 (en) Attachment surface
GB9916729D0 (en) Fuller for the treatment of leather,pelts and the like
CA95616S (en) Tanned hide
EP1566444A3 (en) Yield-related genes
MXPA03010633A (es) Metodo para trastornos de resequedad de ojos.
BG104379U (en) Removable modular lining for safety metal hats
AUPR127900A0 (en) Embryonic stem cells and neural progenitor cells derived therefrom 2)
AUPR292001A0 (en) Embryonic stem cells and neural progenitor cells derived therefrom (3)

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100223